2 Results for "

AAV-based gene therapy

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "AAV-based gene therapy" in MCE Product Catalog:

Cat. No.: HY-P992154
Synonyms: KJ-103
Ricefidase (KJ-103) is a recombinant human immunoglobulin G-degrading enzyme. Ricefidase efficiently cleaves human IgG at the hinge region. Ricefidase rapidly reduces IgG levels. Ricefidase has low immunogenicity and clears AAV neutralizing antibodies. Ricefidase is applicable to research related to desensitization of all IgG subclasses and improvement of the suitability of AAV-based gene therapy .
loading...
    loading...
Cat. No.: HY-49538C
CAS No.: 1246958-42-8
Research Areas:  

Cardiovascular Disease

ASP7967 hemifumarate is an orally active ligand of the RNA aptamer AC17-4 with a Kd of 12 nM. ASP7967 hemifumarate binds AC17-4 to regulate aptazyme-based and exon-skipping riboswitches, thereby enabling small-molecule-controlled transgene expression without exogenous protein factors. ASP7967 hemifumarate can be used for the study of synthetic RNA switches, gene expression regulation and AAV-based gene therapy-related expression control .
loading...
    loading...